Home> Products> pioglitazone 15mg

{ "products": [ { "_id": "6825c6cc966e2a18bb4b35a6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPA PIO", "description": "GLIDAPA PIO is a combination oral medication specially formulated to help manage type 2 diabetes mellitus. It combines two powerful antidiabetic agents, dapagliflozin and pioglitazone, to effectively control blood sugar levels. This medication is prescribed to patients when diet and exercise alone do not provide adequate glycemic control. By addressing blood glucose regulation through different mechanisms, GLIDAPA PIO helps reduce the risk of diabetes-related complications and supports overall metabolic health.\n\nKey Ingredients\nDapagliflozin (10mg): A sodium-glucose co-transporter 2 (SGLT2) inhibitor that helps lower blood sugar by increasing the excretion of glucose through urine.\n\nPioglitazone (15mg): A thiazolidinedione that improves insulin sensitivity by acting on fat, muscle, and liver cells, facilitating better glucose uptake and utilization.\n\nKey Benefits\nHelps maintain stable blood glucose levels in adults with type 2 diabetes.\n\nCombines two complementary mechanisms to enhance blood sugar control.\n\nSupports weight management due to dapagliflozin’s glucose excretion effect.\n\nMay improve insulin sensitivity and reduce insulin resistance.\n\nReduces the risk of diabetes-related complications such as cardiovascular problems when combined with lifestyle changes.\n\nConvenient once-daily tablet formulation.\n\nHow Does It Work?\nDapagliflozin blocks SGLT2 proteins in the kidneys, preventing glucose reabsorption and promoting its elimination through urine, which lowers blood glucose. Pioglitazone acts on insulin-responsive tissues, enhancing the body’s sensitivity to insulin. This dual action helps reduce both insulin resistance and excess blood glucose, providing better overall glycemic control. By targeting different pathways, GLIDAPA PIO offers a synergistic effect to manage type 2 diabetes more effectively.\n\nDirections for Use\nTake GLIDAPA PIO exactly as prescribed by your healthcare provider.\n\nUsually taken once daily, with or without food, at the same time each day.\n\nDo not skip doses or stop the medication without consulting your doctor.\n\nMaintain a balanced diet and regular exercise as advised alongside the medication.\n\nInform your doctor about any other medications you are taking to avoid potential interactions.\n\nSide Effects\nSome patients may experience side effects while taking GLIDAPA PIO, including:\n\nUrinary tract infections or increased urination due to dapagliflozin.\n\nWeight gain or swelling caused by pioglitazone.\n\nRisk of low blood sugar (hypoglycemia) when combined with other antidiabetic drugs.\n\nPossible dizziness or fatigue.\n\nRarely, heart failure or bladder cancer risk (associated with pioglitazone).\n\nIf you notice symptoms like excessive thirst, sudden weight gain, swelling, shortness of breath, or any allergic reactions, seek medical advice immediately.", "price": 255.0, "discountamount": 77.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "medication inform", "pioglitazone risk", "regular exercise", "balanced diet", "doctor maintain", "glucose uptake", "notice symptoms", "antidiabetic drugs", "swelling caused", "advised alongside", "skip doses", "healthcare provider", "effectively directions", "synergistic effect", "glycemic control", "cardiovascular problems", "complementary mechanisms", "fat muscle", "diabetesrelated complications", "insulin resistance", "bodys sensitivity", "glidapa pio", "urine pioglitazone 15mg", "taking glidapa pio", "bladder cancer risk", "improve insulin sensitivity", "improves insulin sensitivity", "glidapa pioglidapa pio", "dapagliflozin weight gain", "increased urination due", "urinary tract infections", "experience side effects", "insulinresponsive tissues enhancing", "liver cells facilitating" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2114, "imageuri": "https://productimages.withfloats.com/actual/6825c6ce65488af627fb2e46.png", "tileimageuri": "https://productimages.withfloats.com/tile/6825c6ce65488af627fb2e46.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-15T10:49:48.361Z", "updatedon": "2025-05-15T10:50:30.602Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapa-pio/2114", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Dapagliflozin 10mg and pioglitazone 15mg tablets", "category": "DIABETIC RANGE", "tags": [ "Dapagliflozin, pioglitazone combination", "Dapagliflozin, pioglitazone combination", "Dapagliflozin Pioglitazone CDSCO" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67a4a65aea4ed7f1f8cd234b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Methotrexate (15mg)", "description": "METROTREX 15 contains Methotrexate 15mg, a potent medication used in the treatment of autoimmune diseases and certain types of cancer. As an antifolate drug, it inhibits cell division, making it effective for managing conditions like rheumatoid arthritis, psoriasis, and leukemia.\n\n \nKey Benefits of METROTREX 15:\n \n\nMETROTREX 15 provides several therapeutic benefits, including:\n\nTreatment of Rheumatoid Arthritis: Helps reduce joint inflammation and pain by suppressing immune responses.\n\nManagement of Psoriasis: Slows down excessive skin cell production, alleviating symptoms of psoriasis.\n\nCancer Therapy: Used in chemotherapy for conditions like leukemia, breast cancer, and lymphoma by inhibiting cancer cell growth.\n\nTreatment of Crohn’s Disease: Helps in managing severe cases of inflammatory bowel disease.\n\n \nHow Does METROTREX 15 Work?\n \n\nMethotrexate 15mg works by inhibiting dihydrofolate reductase (DHFR), an enzyme essential for DNA synthesis and cell division. By blocking this enzyme, METROTREX 15 prevents the rapid multiplication of abnormal cells, making it effective in autoimmune diseases and cancer treatment.\n\n \nDirections for Use of METROTREX 15:\n \n\nTo ensure the safe and effective use of METROTREX 15, follow these guidelines:\n\nTake METROTREX 15 exactly as prescribed by your doctor.\n\nIt is usually taken once a week for autoimmune conditions and as per the oncologist’s recommendation for cancer therapy.\n\nSwallow the tablet whole with water, preferably after meals to reduce stomach irritation.\n\nRegular monitoring of blood tests is necessary to assess the drug’s effects.\n\n \nSide Effects of METROTREX 15:\n \n\nWhile METROTREX 15 is effective, it may cause some side effects, including:\n\nCommon Side Effects:\n\nNausea and vomiting\n\nFatigue\n\nMouth ulcers\n\nHair loss\n\nDizziness\n\nSerious Side Effects:\n\nLiver toxicity\n\nKidney dysfunction\n\nSuppressed bone marrow function leading to low blood cell counts\n\nIncreased risk of infections\n\nLung inflammation\n\nSeek immediate medical attention if you experience severe side effects.", "price": 155.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "metrotrex 15", "metrotrex 15 follow", "autoimmune conditions", "medical attention", "side effects", "blood tests", "water preferably", "oncologists recommendation", "rapid multiplication", "cell division", "dna synthesis", "enzyme essential", "antifolate drug", "autoimmune diseases", "potent medication", "methotrexate 15mg", "methotrexate 15mgmetrotrex 15", "managing conditions", "therapeutic benefits", "psoriasis slows", "cancer treatment directions", "psoriasis cancer therapy", "managing severe cases", "leukemia key benefits", "cancer therapy swallow", "leukemia breast cancer", "rheumatoid arthritis psoriasis", "abnormal cells making", "inflammatory bowel disease", "crohns disease helps" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2051, "imageuri": "https://productimages.withfloats.com/actual/67a4a66d145c10370e023f04.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a4a66d145c10370e023f04.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-06T12:08:58.343Z", "updatedon": "2025-02-06T12:08:58.343Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/methotrexate-15mg-/2051", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "METROTREX 15 ", "category": "", "tags": [ "Methotrexate 15 mg uses", "Methotrexate 15 mg Tablet price", "Methotrexate 15 mg Uses in Hindi", "Folitrax 15 mg tablet price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666ab4987e4bb91e30921215", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MIRTAZPRIME 15 ", "description": "MIRTAZPRIME 15 \nMirtazapine (15mg)\nIntroduction:\n\nMIRTAZPRIME 15 contains Mirtazapine (15 mg), an antidepressant medication primarily used to treat major depressive disorder (MDD) and anxiety disorders. Mirtazapine belongs to a class of medications known as tetracyclic antidepressants and works by balancing chemicals in the brain that affect mood.\nKey Features and Benefits:\n\nEffective Antidepressant: Mirtazapine is highly effective in alleviating symptoms of depression, including persistent sadness, loss of interest in activities, and feelings of hopelessness.\nAnxiety Relief: Besides treating depression, Mirtazapine is beneficial for managing anxiety symptoms, providing a calming effect and reducing anxiety levels.\nImproved Sleep: Mirtazapine has sedative properties, which can help improve sleep patterns in individuals with insomnia related to depression or anxiety.\nAppetite Stimulation: Mirtazapine can stimulate appetite, making it useful for patients experiencing weight loss or poor appetite due to depression.\nRapid Onset: Mirtazapine often begins to show benefits within one to two weeks of starting treatment, offering quicker relief from depressive symptoms compared to some other antidepressants.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of MIRTAZPRIME 15 is 15 mg taken once daily, usually at bedtime due to its sedative effects.\nMaintenance Dosage: The dosage may be gradually increased by a healthcare provider based on the patient's response to treatment. The usual maintenance dose ranges from 15 mg to 45 mg per day.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Mirtazapine at the same time each day to maintain consistent medication levels in the bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/mirtazprime-15-133586", "price": 89.0, "discountamount": 26.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "MDD", "day", "food", "mood", "15 mg", "EMAIL", "water", "45 mg", "brain", "class", "tablet", "bedtime", "interest", "feelings", "insomnia", "patients", "Benefits", "response", "treatment", "same time", "chemicals", "activities", "depression", "weight loss", "MIRTAZPRIME", "medications", "Rapid Onset", "individuals", "bloodstream", "information", "Mirtazapine", "sterispharma", "hopelessness", "sterisonline", "Key Features", "Introduction", "CALL/WHATSAPP", "poor appetite", "anxiety levels", "calming effect", "Administration", "sleep patterns", "quicker relief", "Improved Sleep", "Initial Dosage", "Anxiety Relief", "anxiety symptoms", "sedative effects", "one to two weeks", "anxiety disorders", "persistent sadness", "Maintenance Dosage", "sedative properties", "healthcare provider", "depressive symptoms", "Appetite Stimulation", "typical starting dose", "other antidepressants", "usual maintenance dose", "Effective Antidepressant", "antidepressant medication", "major depressive disorder", "tetracyclic antidepressants", "consistent medication levels" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1854, "imageuri": "https://productimages.withfloats.com/actual/666ab49bf068be46bdeac897.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666ab49bf068be46bdeac897.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T08:58:00.24Z", "updatedon": "2024-06-26T10:59:13.26Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/mirtazprime-15-/1854", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MIRTAZPRIME 15 ", "category": "NEUROLOGYRANGE", "tags": [ "mirtazapine 15mg side effects", "Mirtazapine (15mg)", "", "mirtazapine 15 mg used for", "mirtazapine warnings" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66696701bd5a4b1cb085393e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CBENZPRIME ER 15 ", "description": "CBENZPRIME ER 15 \nCyclobenzaprine HCl Tablets ER(15mg)\nIntroduction\nCBENZPRIME ER 15 contains Cyclobenzaprine Hydrochloride (15mg) in an extended-release formulation, designed to provide sustained relief from muscle spasms associated with acute, painful musculoskeletal conditions. Cyclobenzaprine is a well-known muscle relaxant that helps alleviate pain and improve mobility by acting on the central nervous system (CNS) to relax muscles.\n\nKey Ingredient and Its Benefits\nCyclobenzaprine HCl (15mg)\nMuscle Relaxant: Cyclobenzaprine effectively relieves muscle spasms by inhibiting nerve impulses that cause pain and muscle contraction.\nExtended-Release Formulation: The extended-release formulation ensures a steady release of the medication over time, providing long-lasting relief from muscle spasms and pain.\nPain Reduction: Cyclobenzaprine helps reduce the discomfort caused by muscle spasms, promoting better mobility and comfort.\nShort-Term Use: Typically prescribed for short-term use in conjunction with rest and physical therapy, Cyclobenzaprine aids in the recovery from acute musculoskeletal conditions.\nBenefits of CBENZPRIME ER 15\nLong-Lasting Relief: The extended-release formulation provides sustained relief from muscle spasms and pain throughout the day.\nEffective Muscle Relaxation: CBENZPRIME ER 15 promotes muscle relaxation, reducing pain and discomfort associated with muscle spasms.\nImproved Mobility: By alleviating muscle spasms, it enhances mobility and range of motion, making it easier to perform daily activities and engage in physical therapy.\nConvenient Dosage: The once-daily dosing of CBENZPRIME ER 15 offers convenience and ensures consistent medication levels in the bloodstream.\nDosage and Administration\nDosage\nMuscle Spasms: The recommended dosage for adults is one extended-release tablet (15mg) taken once daily. The dosage may be adjusted by the healthcare provider based on the patient’s response and tolerability, with a maximum recommended dose of 30mg per day.\nAdministration\nOral Use: Swallow the tablet whole with a full glass of water. Do not crush, chew, or break the tablet, as it is designed to release the medication slowly over time.\nConsistency: For optimal results, take CBENZPRIME ER 15 at the same time each day to maintain a consistent level of the medication in your bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/cbenzprime-er-15-133928", "price": 189.0, "discountamount": 56.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "CNS", "rest", "30mg", "EMAIL", "Order", "water", "range", "motion", "adults", "patient", "muscles", "recovery", "Oral Use", "Benefits", "response", "same time", "discomfort", "full glass", "Consistency", "information", "convenience", "bloodstream", "conjunction", "Introduction", "sterisonline", "sterispharma", "daily dosing", "tolerability", "CALL/WHATSAPP", "muscle spasms", "CBENZPRIME ER", "Short-Term Use", "steady release", "nerve impulses", "Key Ingredient", "Pain Reduction", "optimal results", "muscle relaxant", "sustained relief", "physical therapy", "consistent level", "daily activities", "Convenient Dosage", "Improved Mobility", "muscle contraction", "healthcare provider", "long-lasting relief", "Cyclobenzaprine aids", "Administration Dosage", "central nervous system", "maximum recommended dose", "one extended-release tablet", "Effective Muscle Relaxation", "extended-release formulation", "consistent medication levels", "Cyclobenzaprine Hydrochloride", "Cyclobenzaprine HCl Tablets ER", "acute musculoskeletal conditions", "painful musculoskeletal conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1801, "imageuri": "https://productimages.withfloats.com/actual/666967055e294343790b76bf.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666967055e294343790b76bf.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-12T09:14:41.453Z", "updatedon": "2024-06-27T06:34:18.57Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cbenzprime-er-15-/1801", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CBENZPRIME ER 15 ", "category": "NEUROLOGY RANGE", "tags": [ "cbenzprime er 15 uses", "cbenzprime er 15 side effects", "cbenzprime er 15 price", "cbenzprime er 15 benefits", "Cyclobenzaprine HCl Tablets ER(15mg)", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6666db5153acd61acc4cd62e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MELOAXIS 15 ", "description": "MELOAXIS 15 \nMeloxicam Tablets BP (15mg)\nIntroduction\nMELOAXIS 15 contains Meloxicam (15mg), a potent nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation associated with various conditions such as arthritis, osteoarthritis, and rheumatoid arthritis. Meloxicam works by inhibiting the enzymes that produce prostaglandins, which are chemicals responsible for pain, fever, and inflammation.\n\nKey Ingredient and Its Benefits\nMeloxicam (15mg)\nAnti-Inflammatory Properties: Meloxicam effectively reduces inflammation, making it useful for treating conditions such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis.\nPain Relief: By inhibiting the synthesis of prostaglandins, Meloxicam provides relief from mild to moderate pain associated with musculoskeletal conditions, headaches, and menstrual cramps.\nAntipyretic: Meloxicam helps lower fever by acting on the body's temperature-regulating center in the brain.\nBenefits of MELOAXIS 15\nEffective Pain Management: MELOAXIS 15 is highly effective in managing pain associated with various inflammatory conditions, improving the quality of life for patients.\nReduces Inflammation: The anti-inflammatory properties of Meloxicam help reduce swelling, redness, and discomfort in affected areas.\nFever Reduction: Meloxicam's antipyretic effects help lower fever, providing relief from febrile conditions.\nLong-Lasting Relief: Meloxicam has a longer half-life compared to some other NSAIDs, providing extended relief from symptoms with a once-daily dosage.\nVersatile Use: MELOAXIS 15 can be used to treat a wide range of conditions, including arthritis, gout, bursitis, tendinitis, and more.\nDosage and Administration\nDosage\nRecommended Dosage: The typical dosage of MELOAXIS 15 is one tablet taken once daily, depending on the severity of the condition and the patient's response to treatment. The exact dosage should be determined by a healthcare provider.\nAdministration\nOral Use: Swallow the tablet whole with a full glass of water. It is best taken with food or milk to reduce the risk of gastrointestinal discomfort.\nConsistency: For optimal results, take MELOAXIS 15 at the same time each day as prescribed by your healthcare provider.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \nBUY NOW \nhttps://www.sterisonline.com/product/meloaxis-15-133946", "price": 33.0, "discountamount": 9.9, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "BUY", "food", "milk", "risk", "gout", "body", "EMAIL", "water", "brain", "enzymes", "quality", "redness", "mild to", "MELOAXIS", "patients", "swelling", "symptoms", "Oral Use", "bursitis", "severity", "response", "same time", "treatment", "headaches", "synthesis", "chemicals", "full glass", "tendinitis", "one tablet", "wide range", "information", "Consistency", "Pain Relief", "inflammation", "Introduction", "sterispharma", "sterisonline", "other NSAIDs", "daily dosage", "exact dosage", "CALL/WHATSAPP", "Versatile Use", "moderate pain", "affected areas", "Key Ingredient", "osteoarthritis", "prostaglandins", "typical dosage", "optimal results", "extended relief", "Fever Reduction", "longer half-life", "menstrual cramps", "various conditions", "Benefits Meloxicam", "febrile conditions", "Recommended Dosage", "Long-Lasting Relief", "antipyretic effects", "healthcare provider", "rheumatoid arthritis", "Meloxicam Tablets BP", "Administration Dosage", "ankylosing spondylitis", "Effective Pain Management", "musculoskeletal conditions", "gastrointestinal discomfort", "Anti-Inflammatory Properties", "temperature-regulating center", "various inflammatory conditions", "potent nonsteroidal anti-inflammatory drug" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1679, "imageuri": "https://productimages.withfloats.com/actual/667d3f836c582d228f45be14.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d3f836c582d228f45be14.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-10T10:54:09.638Z", "updatedon": "2024-06-29T09:53:23.536Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/meloaxis-15-/1679", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MELOAXIS 15 ", "category": "ORTHOLOGYRANG", "tags": [ "MELOAXIS 15 mg", "Meloxicam Tablets BP 15mg dose", "does meloxicam affect blood pressure", "Meloxicam Tablets BP 15mg", "Meloxicam Tablets BP 15mg", "Meloxicam Tablets BP 15mg", "does meloxicam 15 mg raise blood pressure" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6664269dea22b014e8af4e3f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LANSOSTRUM 15 JUNIOR", "description": "LANSOSTRUM 15 JUNIOR\nLansoprazole (15mg)\nLansostrum 15 Junior contains Lansoprazole (15mg), a proton pump inhibitor (PPI) used to treat acid-related conditions such as gastroesophageal reflux disease (GERD), ulcers, and Zollinger-Ellison syndrome.\n\nMechanism of Action: Lansoprazole works by reducing the production of stomach acid by inhibiting the proton pumps in the stomach lining. This helps in relieving symptoms such as heartburn, acid reflux, and indigestion.\n\nIndications: It is commonly prescribed to children and adolescents for the treatment of GERD and related symptoms. It can also be used to heal and prevent ulcers in the stomach and intestine caused by excessive acid production.\n\nDosage: The typical dosage of Lansostrum 15 Junior is 15mg once daily, usually taken before a meal. The dosage may vary depending on the individual's condition and response to treatment.\n\nSide Effects: Common side effects may include headache, diarrhea, nausea, and abdominal pain. Rare but serious side effects may include severe allergic reactions, liver problems, and bone fractures.\n\nPrecautions: It is important to take Lansostrum 15 Junior exactly as prescribed by a healthcare professional. It should not be used in case of allergies to lansoprazole or similar medications. Long-term use may increase the risk of certain side effects, so it is advisable to use the lowest effective dose for the shortest duration necessary.\n\nConclusion: Lansostrum 15 Junior with Lansoprazole (15mg) is an effective medication for managing acid-related disorders in children and adolescents. It provides relief from symptoms and helps in healing and preventing ulcers. However, it should be used with caution and under medical supervision to minimize potential side effects and ensure optimal treatment outcomes.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/lansostrum-15-junior-134373\n\n\n\n\n\n\n", "price": 75.0, "discountamount": 30.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "PPI", "15mg", "risk", "meal", "case", "Rare", "GERD", "Email", "ulcers", "relief", "nausea", "healing", "children", "response", "headache", "diarrhea", "WhatsApp", "allergies", "intestine", "heartburn", "Mechanism", "individual", "Conclusion", "acid reflux", "adolescents", "information", "Indications", "indigestion", "Precautions", "sterispharma", "sterisonline", "proton pumps", "Lansoprazole", "stomach acid", "Long-term use", "liver problems", "typical dosage", "stomach lining", "abdominal pain", "bone fractures", "related symptoms", "Common side effects", "similar medications", "medical supervision", "effective medication", "serious side effects", "Lansostrum 15 Junior", "proton pump inhibitor", "lowest effective dose", "acid-related disorders", "potential side effects", "healthcare professional", "acid-related conditions", "severe allergic reactions", "excessive acid production", "optimal treatment outcomes", "Zollinger-Ellison syndrome", "shortest duration necessary", "gastroesophageal reflux disease" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1567, "imageuri": "https://productimages.withfloats.com/actual/6664269f055ca12fa34e82a8.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/6664269f055ca12fa34e82a8.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-08T09:38:37.063Z", "updatedon": "2024-06-29T09:11:45.493Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//lansostrum-15-junior/1567", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LANSOSTRUM 15 JUNIOR", "category": "GASTROLOGYRANGE", "tags": [ "LANSOSTRUM 15 JUNIOR", "Lansoprazole (15mg)", "Lansoprazole 15 mg dosage", "What not to take with lansoprazole", "Lansoprazole side effects", "Lansoprazole 15 mg how to use", "Lansoprazole 15 mg for child" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662c4c88ecffe165c354dc1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VILDIABATE PIO ", "description": "VILDIABATE PIO \nVildagliptin 50 mg & Pioglitazone Hydrochloride 15 mg\nIntroduction to VILDIABATE PIO\nVILDIABATE PIO is a combination medication designed for the effective management of type 2 diabetes mellitus. It contains two active ingredients: Vildagliptin 50mg and Pioglitazone Hydrochloride 15mg. This dual-action formula targets different aspects of glucose regulation, providing comprehensive blood sugar control. It is used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nKey Components and Their Mechanisms\nVildagliptin 50mg\nVildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by:\n\nEnhancing Incretin Levels: Vildagliptin inhibits the DPP-4 enzyme, which degrades incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These hormones increase insulin secretion and decrease glucagon release in a glucose-dependent manner.\nImproving Postprandial Glucose Control: By enhancing the action of incretin hormones, Vildagliptin helps regulate blood sugar levels after meals.\nPioglitazone Hydrochloride 15mg\nPioglitazone is a thiazolidinedione that improves insulin sensitivity in muscle and adipose (fat) tissues. It works by:\n\nIncreasing Insulin Sensitivity: Pioglitazone enhances the body's response to insulin, allowing for better glucose uptake and utilization by cells.\nReducing Hepatic Glucose Production: Pioglitazone decreases the amount of glucose produced by the liver, helping to lower fasting blood sugar levels.\nBenefits of VILDIABATE PIO\nComprehensive Blood Sugar Control\nFasting and Postprandial Glucose Management: The combination of Vildagliptin and Pioglitazone effectively manages both fasting and postprandial (after-meal) blood sugar levels.\nImproved Insulin Sensitivity and Secretion: Vildagliptin enhances insulin secretion in response to meals, while Pioglitazone improves insulin sensitivity in peripheral tissues.\nAdditional Health Benefits\nLow Risk of Hypoglycemia: Vildagliptin has a low risk of causing hypoglycemia (low blood sugar) because it enhances insulin secretion only when blood glucose levels are elevated.\nCardioprotective Effects: Pioglitazone may provide additional cardiovascular benefits, such as improving lipid profiles and reducing inflammation, which can be beneficial for patients with diabetes who are at risk of cardiovascular diseases.\nWeight Management: While Pioglitazone may cause some weight gain due to fluid retention, Vildagliptin is generally weight neutral, balancing the overall effect on body weight.\nDosage and Administration\nRecommended Dosage\nDosage: The typical dosage of VILDIABATE PIO is one tablet taken once daily, preferably with a meal to enhance absorption and reduce gastrointestinal side effects.\nAdministration: Swallow the tablet whole with a glass of water. Do not crush, chew, or split the tablet unless advised by your healthcare provider.\nGuidelines for Optimal Use\nConsistent Use: For best results, take VILDIABATE PIO regularly at the same time each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regular monitoring of blood sugar levels is essential to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vildiabate-pio-134257\n", "price": 295.0, "discountamount": 88.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "diet", "Order", "meals", "EMAIL", "cells", "liver", "water", "glass", "GLP-1", "amount", "muscle", "adults", "Fasting", "adipose", "patients", "Low Risk", "exercise", "readings", "response", "Enhancing", "same time", "one tablet", "Mechanisms", "Increasing", "Guidelines", "absorption", "utilization", "Optimal Use", "information", "body weight", "Adjustments", "weight gain", "DPP-4 enzyme", "inflammation", "Introduction", "Vildagliptin", "Hypoglycemia", "sterispharma", "best results", "fat) tissues", "sterisonline", "CALL/WHATSAPP", "Administration", "VILDIABATE PIO", "glucose uptake", "Key Components", "Consistent Use", "treatment plan", "overall effect", "lipid profiles", "typical dosage", "Incretin Levels", "low blood sugar", "fluid retention", "glycemic control", "glucagon release", "DPP-4) inhibitor", "Weight Management", "insulin secretion", "incretin hormones", "different aspects", "thiazolidinedione", "peripheral tissues", "glucose regulation", "Regular monitoring", "healthcare provider", "dual-action formula", "insulin sensitivity", "blood glucose levels", "effective management", "dipeptidyl peptidase-4", "two active ingredients", "combination medication", "cardiovascular diseases", "Cardioprotective Effects", "type 2 diabetes mellitus", "meal) blood sugar levels", "glucose-dependent manner", "Recommended Dosage Dosage", "Pioglitazone Hydrochloride", "Additional Health Benefits", "Hepatic Glucose Production", "gastrointestinal side effects", "Postprandial Glucose Management", "comprehensive blood sugar control", "additional cardiovascular benefits", "Improving Postprandial Glucose Control", "glucose-dependent insulinotropic peptide" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1512, "imageuri": "https://productimages.withfloats.com/actual/667d3d8c5443982e2f655655.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d3d8c5443982e2f655655.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T08:28:56.298Z", "updatedon": "2024-06-27T10:23:02.274Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/vildiabate-pio-/1512", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VILDIABATE PIO ", "category": "DIABETIC RANGE", "tags": [ "vildagliptin metformin hydrochloride tablets uses", "vildagliptin + metformin + glimepiride combination", "vildagliptin 50 mg side effects", "vildagliptin and pioglitazone hydrochloride" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661afd366170d1ff8cb4626", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIGLICLAGLAZE 60 ", "description": "TRIGLICLAGLAZE 60 \nGliclazide 60mg (SR) Pioglitazone 15mg and Metformin HCL 500mg(SR)\nTRIGLICLAGLAZE 60 is a combination medication designed to effectively manage type 2 diabetes mellitus by addressing multiple aspects of glucose regulation. It combines three key components: Gliclazide 60mg (SR), Pioglitazone 15mg, and Metformin HCI 500mg (SR), each contributing to improved blood sugar control through distinct mechanisms of action.\n\nGliclazide 60mg (SR): Gliclazide is a sulfonylurea medication that stimulates the pancreas to release insulin. This insulin release helps lower blood sugar levels, especially after meals, by facilitating glucose uptake into cells.\n\nPioglitazone 15mg: Pioglitazone belongs to the thiazolidinedione class and works by improving insulin sensitivity in peripheral tissues such as muscle and fat cells. Enhanced insulin sensitivity allows for better utilization of glucose, reducing insulin resistance and promoting more efficient blood sugar management.\n\nMetformin HCI 500mg (SR): Metformin is a biguanide medication that primarily works by reducing glucose production in the liver and increasing insulin sensitivity in muscle cells. It also improves glucose uptake by cells and reduces the absorption of glucose from the digestive tract.\n\nKey Benefits of TRIGLICLAGLAZE 60:\nComprehensive Glucose Control: By combining Gliclazide (SR), Pioglitazone, and Metformin HCI (SR), TRIGLICLAGLAZE 60 offers comprehensive control over blood sugar levels throughout the day.\n\nStimulates Insulin Release: Gliclazide's action in stimulating insulin release from the pancreas helps manage postprandial (after-meal) glucose spikes, contributing to overall glucose control.\n\nImproves Insulin Sensitivity: Pioglitazone enhances insulin sensitivity in tissues, leading to better glucose uptake and utilization by cells. This helps reduce insulin resistance, a common feature of type 2 diabetes.\n\nReduces Glucose Production: Metformin HCI lowers glucose production in the liver and improves insulin action in muscle cells, leading to lower fasting blood sugar levels and enhanced glucose utilization.\n\nExtended Release Formulation: The sustained-release formulations of Gliclazide and Metformin ensure a gradual and prolonged release of the medications, providing consistent blood sugar control and minimizing the risk of hypoglycemia or hyperglycemia.\n\nDosage and Administration:\nTRIGLICLAGLAZE 60 is typically taken orally once or twice daily, with meals to reduce gastrointestinal side effects.\nDosage adjustments may be required based on blood sugar levels and individual response to treatment. Follow your healthcare provider's instructions.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/trigliclaglaze-60-134279", "price": 155.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "SR", "day", "risk", "meals", "Order", "liver", "EMAIL", "gradual", "fasting", "pancreas", "Enhanced", "treatment", "fat cells", "absorption", "information", "medications", "muscle cells", "Pioglitazone", "sterisonline", "Key Benefits", "hypoglycemia", "instructions", "sterispharma", "postprandial", "hyperglycemia", "CALL/WHATSAPP", "Metformin HCL", "Metformin HCI", "Administration", "glucose uptake", "TRIGLICLAGLAZE", "common feature", "glucose spikes", "insulin action", "insulin release", "Gliclazide 60mg", "digestive tract", "multiple aspects", "prolonged release", "Dosage adjustments", "peripheral tissues", "blood sugar levels", "glucose production", "insulin resistance", "glucose regulation", "distinct mechanisms", "healthcare provider", "individual response", "glucose utilization", "insulin sensitivity", "three key components", "biguanide medication", "comprehensive control", "combination medication", "sulfonylurea medication", "thiazolidinedione class", "overall glucose control", "type 2 diabetes mellitus", "Extended Release Formulation", "Comprehensive Glucose Control", "gastrointestinal side effects", "sustained-release formulations", "consistent blood sugar control", "efficient blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1485, "imageuri": "https://productimages.withfloats.com/actual/6661afd7f21358d53af3cd71.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661afd7f21358d53af3cd71.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:47:15.16Z", "updatedon": "2024-06-28T12:12:27Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trigliclaglaze-60-/1485", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRIGLICLAGLAZE 60 ", "category": "DIABETIC RANGE", "tags": [ "TRIGLICLAGLAZE 60", "Gliclazide 60mg (SR)", "Pioglitazone 15mg", "Metformin HCL 500mg(SR)", "Metformin SR 500mg uses", "Metformin SR 500 price", "Metformin SR 500 side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661aea4d91d281c30c76019", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRI GLIBEN FORTE ", "description": "TRI GLIBEN FORTE \nGlibenclamide (5mg), Metformin HCI (500mg), Pioglitazone (15mg)\nTRI GLIBEN FORTE is a combination medication containing Glibenclamide, Metformin HCI, and Pioglitazone. This combination is commonly prescribed for the management of type 2 diabetes mellitus, a condition characterized by high blood sugar levels due to insulin resistance or inadequate insulin production.\n\nGlibenclamide (5mg): Glibenclamide belongs to the sulfonylurea class of medications. It works by stimulating the pancreas to release insulin, thereby lowering blood sugar levels. Glibenclamide also helps the body use insulin more effectively.\n\nMetformin HCI (500mg): Metformin is a biguanide medication that reduces glucose production in the liver, decreases intestinal glucose absorption, and enhances insulin sensitivity in peripheral tissues. It is a first-line treatment for type 2 diabetes and helps improve overall glycemic control.\n\nPioglitazone (15mg): Pioglitazone is a thiazolidinedione medication that improves insulin sensitivity in muscle and adipose (fat) tissues. It reduces glucose production in the liver and enhances glucose uptake in peripheral tissues, leading to better blood sugar control.\n\nKey Benefits of TRI GLIBEN FORTE:\nComprehensive Glucose Control: The combination of Glibenclamide, Metformin HCI, and Pioglitazone targets multiple pathways involved in glucose metabolism, providing comprehensive control over blood sugar levels.\n\nStimulates Insulin Release: Glibenclamide stimulates insulin secretion from the pancreas, especially after meals, helping to regulate postprandial (after-meal) glucose spikes.\n\nImproves Insulin Sensitivity: Metformin and Pioglitazone improve insulin sensitivity in cells, allowing for better utilization of glucose and reducing insulin resistance.\n\nReduces Hepatic Glucose Production: Metformin and Pioglitazone both reduce the production of glucose in the liver, helping to lower fasting blood sugar levels.\n\nCardiometabolic Benefits: Pioglitazone may have additional benefits for cardiovascular health, such as reducing inflammation and improving lipid profiles.\n\nDosage and Administration:\nThe typical dosage of TRI GLIBEN FORTE is one tablet taken orally once or twice daily, as prescribed by your healthcare provider.\nIt is usually taken with meals to reduce the risk of gastrointestinal side effects.\nFollow your doctor's instructions regarding dosage adjustments based on your blood sugar levels and response to treatment.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/tri-gliben-forte-133450", "price": 74.0, "discountamount": 22.2, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "body", "risk", "Order", "500mg", "EMAIL", "liver", "meals", "cells", "muscle", "doctor", "adipose", "response", "pancreas", "condition", "management", "one tablet", "utilization", "information", "medications", "Pioglitazone", "sterispharma", "Key Benefits", "fat) tissues", "instructions", "postprandial", "inflammation", "sterisonline", "CALL/WHATSAPP", "Metformin HCI", "Glibenclamide", "Administration", "typical dosage", "glucose uptake", "lipid profiles", "Insulin Release", "TRI GLIBEN FORTE", "insulin secretion", "multiple pathways", "dosage adjustments", "glucose metabolism", "peripheral tissues", "sulfonylurea class", "insulin resistance", "blood sugar control", "healthcare provider", "insulin sensitivity", "additional benefits", "biguanide medication", "first-line treatment", "meal) glucose spikes", "cardiovascular health", "comprehensive control", "combination medication", "high blood sugar levels", "overall glycemic control", "Cardiometabolic Benefits", "type 2 diabetes mellitus", "Hepatic Glucose Production", "thiazolidinedione medication", "intestinal glucose absorption", "Comprehensive Glucose Control", "gastrointestinal side effects", "inadequate insulin production" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1483, "imageuri": "https://productimages.withfloats.com/actual/6661aea6dd39d2ccddbc8e54.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661aea6dd39d2ccddbc8e54.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:42:12.134Z", "updatedon": "2024-06-28T12:16:49.307Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tri-gliben-forte-/1483", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRI GLIBEN FORTE ", "category": "DIABETIC RANGE", "tags": [ "TRI GLIBEN FORTE", "Glibenclamide (5mg)", "Metformin HCI (500mg)", "Pioglitazone (15mg)", "Pioglitazone 15 mg uses", "Pioglitazone side effects", "Pioglitazone uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }